Suppr超能文献

AcSDKP降低小鼠急性髓系白血病干细胞热灌注方案中热诱导的血液毒性

Reduction of heat-induced haemotoxicity in a hyperthermic purging protocol of murine acute myeloid leukaemic stem cells by AcSDKP.

作者信息

Wierenga P K, Dillingh J H, Konings A W

机构信息

Department of Radiobiology, University of Groningen, The Netherlands.

出版信息

Br J Haematol. 1997 Dec;99(3):692-8. doi: 10.1046/j.1365-2141.1997.4403251.x.

Abstract

The tetrapeptide AcSDKP (Goralatide) is a cytokine with known inhibitory effects on cell proliferation. Many purging agents used in autologous bone marrow transplantation protocols, including hyperthermia, preferentially kill cycling cells. A pretreatment with Goralatide offers a possibility to reduce the haemotoxicity in many purging settings. The impact of Goralatide on the hyperthermic purging protocol was investigated in normal and myeloid leukaemic (SA8) murine cells. The median survival time after transplantation (i.e. leukaemia incidences) was used as an in vivo parameter to determine the effects on leukaemic cells. The hyperthermic effect on normal and leukaemic cells was also investigated in vitro using the cobblestone area-forming cell (CAFC) assay. A heat treatment of 90 min at 43 degrees C resulted in a 4-log depletion of leukaemic stem cells. For normal progenitor cells (CFU-GM) a 2-log cell kill was shown. The reduction in proliferative activity of the CFU-GM after an 8 h incubation with 10(-9) M Goralatide resulted in a decrease in the heat sensitivity of the progenitor subset to approximately a 1-log cell kill. The leukaemic precursor cells seem insensitive to Goralatide inhibition, implicating an increase in the therapeutic window of the hyperthermic purging protocol. Finally, simulated remission bone marrow (5% leukaemic blasts) was incubated with Goralatide followed by a heat treatment of 90 min at 43 degrees C. Lethally irradiated (10 Gy) mice transplanted with heat-treated remission bone marrow (10(6) normal bone marrow cells versus 5 x 10(4) leukaemic cells) died of aplasia while Goralatide-pretreated remission bone marrow could rescue the irradiated mice without revealing leukaemic engraftment. These findings confirmed the enhanced protection against hyperthermia of the normal haemopoietic subsets by Goralatide and thus increased the success of the hyperthermic purging protocol.

摘要

四肽AcSDKP(戈拉替德)是一种对细胞增殖具有已知抑制作用的细胞因子。许多用于自体骨髓移植方案的清除剂,包括热疗,优先杀死处于增殖周期的细胞。用戈拉替德进行预处理为在许多清除情况下降低血液毒性提供了一种可能性。在正常和髓系白血病(SA8)小鼠细胞中研究了戈拉替德对热清除方案的影响。移植后的中位生存时间(即白血病发病率)被用作体内参数来确定对白血病细胞的影响。还使用鹅卵石区域形成细胞(CAFC)试验在体外研究了热疗对正常和白血病细胞的影响。在43℃下进行90分钟的热处理导致白血病干细胞减少4个对数级。对于正常祖细胞(CFU-GM),显示有2个对数级的细胞杀伤。用10⁻⁹ M戈拉替德孵育8小时后,CFU-GM增殖活性的降低导致祖细胞亚群对热的敏感性降低至约1个对数级的细胞杀伤。白血病前体细胞似乎对戈拉替德抑制不敏感,这意味着热清除方案的治疗窗口有所增加。最后,将模拟缓解期骨髓(5%白血病母细胞)与戈拉替德一起孵育,然后在43℃下进行90分钟的热处理。用热处理后的缓解期骨髓(10⁶个正常骨髓细胞对5×10⁴个白血病细胞)移植的经致死剂量照射(10 Gy)的小鼠死于再生障碍性贫血,而经戈拉替德预处理的缓解期骨髓可以挽救受照射的小鼠,且未出现白血病植入。这些发现证实了戈拉替德对正常造血亚群热疗的增强保护作用,从而提高了热清除方案的成功率。

相似文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验